News

The new plan allows plaintiffs who sued Purdue to opt in to receive their settlement or reserve their right to file a civil suit against the billionaire Sackler family.
Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...
Purdue Pharma has filed a new reorganization plan that aims to deliver more than $7.4 billion in cash to creditors, subject to certain reserves, to compensate victims and abate the opioid crisis.
Purdue Pharma on Wednesday filed a new bankruptcy reorganization plan to resolve mass lawsuits alleging that the OxyContin maker and its Sackler family owners contributed to the opioid crisis.
Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.
Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic ...
The pharmaceutical industry is on the brink of massive transformation driven by cutting-edge technology and strategic collaboration. Purdue University is on the forefront of Pharma 4.0 by partnering ...
Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in cash in the latest plan to settle thousands of lawsuits over the toll of ...
STAMFORD, Conn., March 19, 2025--(BUSINESS WIRE)--Purdue Pharma L.P. ("Purdue") today filed a Chapter 11 Plan of Reorganization (the "Plan") and related disclosure statement with the United States ...
Purdue Pharma has filed a new bankruptcy plan that details how the funds will be allocated and the proportion paid by its owners, nearly two months after agreeing to a $7.4bn opioid settlement.
Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court ...